Literature DB >> 16909020

Excitotoxicity and amyotrophic lateral sclerosis.

P Van Damme1, M Dewil, W Robberecht, L Van Den Bosch.   

Abstract

Since its description by Charcot more than 130 years ago, the pathogenesis of selective motor neuron degeneration in amyotrophic lateral sclerosis (ALS) remains unsolved. Over the years, many pathogenic mechanisms have been proposed. Amongst others these include: oxidative stress, excitotoxicity, aggregate formation, inflammation, growth factor deficiency and neurofilament disorganization. This multitude of contributing factors indicates that ALS is a complex disease and also suggests that ALS is a multifactorial disorder. Excitotoxicity is not the newest and most spectacular hypothesis in the ALS field, but it is undoubtedly one of the most robust pathogenic mechanisms supported by an impressive amount of evidence. Moreover, the therapeutic efficacy of riluzole, the only drug proven to slow disease progression in ALS, is most likely related to its anti-excitotoxic properties. In this review, we will give an overview of the arguments in favor of the involvement of excitotoxicity in ALS and of the possible mechanisms leading to motor neuron death. We will also summarize the intrinsic properties of motor neurons that render these cells particularly vulnerable to excitotoxicity and could explain the selective vulnerability of motor neurons in ALS. All this information could help to develop new and better therapeutic strategies that could protect motor neurons from excitotoxicity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16909020     DOI: 10.1159/000089620

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  40 in total

1.  Effect of prolonged riluzole exposure on cultured motoneurons in a mouse model of ALS.

Authors:  J E Schuster; R Fu; T Siddique; C J Heckman
Journal:  J Neurophysiol       Date:  2011-10-19       Impact factor: 2.714

2.  Molecular mechanisms of interaction between the neuroprotective substance riluzole and GABA(A)-receptors.

Authors:  K Jahn; F Schlesinger; L J Jin; R Dengler; J Bufler; K Krampfl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-05-06       Impact factor: 3.000

3.  Upregulation of the E3 ligase NEDD4-1 by oxidative stress degrades IGF-1 receptor protein in neurodegeneration.

Authors:  Young-Don Kwak; Bin Wang; Jing Jing Li; Ruishan Wang; Qiyue Deng; Shiyong Diao; Yaomin Chen; Raymond Xu; Eliezer Masliah; Huaxi Xu; Jung-Joon Sung; Francesca-Fang Liao
Journal:  J Neurosci       Date:  2012-08-08       Impact factor: 6.167

Review 4.  Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis.

Authors:  Laura Ferraiuolo; Janine Kirby; Andrew J Grierson; Michael Sendtner; Pamela J Shaw
Journal:  Nat Rev Neurol       Date:  2011-11       Impact factor: 42.937

5.  Multifactorial Gene Therapy Enhancing the Glutamate Uptake System and Reducing Oxidative Stress Delays Symptom Onset and Prolongs Survival in the SOD1-G93A ALS Mouse Model.

Authors:  Chen Benkler; Yael Barhum; Tali Ben-Zur; Daniel Offen
Journal:  J Mol Neurosci       Date:  2015-12-21       Impact factor: 3.444

6.  D-serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosis.

Authors:  Jumpei Sasabe; Tomohiro Chiba; Marina Yamada; Koichi Okamoto; Ikuo Nishimoto; Masaaki Matsuoka; Sadakazu Aiso
Journal:  EMBO J       Date:  2007-08-30       Impact factor: 11.598

7.  Wallerian-like axonal degeneration in the optic nerve after excitotoxic retinal insult: an ultrastructural study.

Authors:  Sarabjit K Saggu; Hiren P Chotaliya; Peter C Blumbergs; Robert J Casson
Journal:  BMC Neurosci       Date:  2010-08-13       Impact factor: 3.288

8.  Branched-chain amino acids induce neurotoxicity in rat cortical cultures.

Authors:  Valentina Contrusciere; Silvia Paradisi; Andrea Matteucci; Fiorella Malchiodi-Albedi
Journal:  Neurotox Res       Date:  2009-09-15       Impact factor: 3.911

9.  Alterations of striatal glutamate transmission in rotenone-treated mice: MRI/MRS in vivo studies.

Authors:  Charbel E-H Moussa; Milan Rusnak; Ayichew Hailu; Anita Sidhu; Stanley T Fricke
Journal:  Exp Neurol       Date:  2007-10-04       Impact factor: 5.330

10.  Upregulation of alpha7 Nicotinic Receptors by Acetylcholinesterase C-Terminal Peptides.

Authors:  Cherie E Bond; Martina Zimmermann; Susan A Greenfield
Journal:  PLoS One       Date:  2009-03-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.